Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
masct:multiple antigens specific cellular therapy (2 trials)
camrelizumab (1 trial)
dendritic cells loaded with 17 antigens (1 trial)
ifosfamide (ifex) (1 trial)
lapatinib (tykerb) (1 trial)
nivolumab (opdivo) (1 trial)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Sarcoma (Phase 1)
Stomach Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Trials (4 total)
Trial APIs (6 total)